TrialJournal of the American Society of Nephrology : JASN2011

Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.

Donald E Kohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.